Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN

  • Ul Ain, Qurrat
  • Chung, Jee Young
  • Kim, Yong-Hee
Citations

WEB OF SCIENCE

98
Citations

SCOPUS

116

초록

Gene therapy by engineered nucleases is a genetic intervention being investigated for curing the hereditary disorders by targeting selected genes with specific nucleotides for establishment, suppression, abolishment of a function or correction of mutation. Here, we review the fast developing technology of targeted genome engineering using site specific programmable nucleases zinc finger nucleases (ZFNs), transcription activator like nucleases (TALENs) and cluster regulatory interspaced short palindromic repeat/CRISPR associated proteins (CRISPR/Cas) based RNA-guided DNA endonucleases (RGENs) and their different characteristics including pros and cons of genome modifications by these nucleases. We have further discussed different types of delivery methods to induce gene editing, novel development in genetic engineering other than nucleases and future prospects.

키워드

Engineered nucleasesGenome silencing vs genome editingGene, protein and cell therapyViral and non-viral delivery systemsZINC-FINGER NUCLEASESSTEM-CELLEMBRYO MICROINJECTIONGENE DISRUPTIONRNADNACRISPRKNOCKOUTCAS9REPAIR
제목
Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN
저자
Ul Ain, QurratChung, Jee YoungKim, Yong-Hee
DOI
10.1016/j.jconrel.2014.12.036
발행일
2015-05
유형
Article; Proceedings Paper
저널명
Journal of Controlled Release
205
페이지
120 ~ 127